Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer's disease spectrum patients: A randomized, double-blind, placebo-controlled study and a two-period extension study [post]

2020 unpublished
doi:10.21203/rs.2.22841/v1 fatcat:kg5zzitarreqnjojzvjinbuosy